Morgan Stanley
-
-
-
-
-
-
-
Novartis shares surge on positive results from key cancer drug trial; a 'best-case scenario'
-
-
-
-
-
-
-
Pre-Open Movers 10/30: (CAA) (ADMS) (DYN) Higher; (PSTI) (CTB) (CENX) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 08/17: (AVEO) (ZU) (KITE) (TSLA) Higher; (ONTX) (MU) (EL) Lower (more...)
-
-
-
-
-
-
-
Grifols (GRFS) to Acquire Novartis' (NVS) Transfusion Diagnostics Unit in $1.7B Deal
-
-
-
-
-
-
-
Notable Analyst Rating Changes 10/21: CAT, CSCO, SYK, FRX Upgraded; LMT, EAT, NVS Downgraded
-
-
-
-
-
-
-
Morgan Stanley Upgrades Novartis (NVS) to Overweight
-
-
224,861 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

